Tianshui Sun

862 total citations · 1 hit paper
14 papers, 556 citations indexed

About

Tianshui Sun is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Tianshui Sun has authored 14 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Obstetrics and Gynecology. Recurrent topics in Tianshui Sun's work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Uterine Myomas and Treatments (3 papers). Tianshui Sun is often cited by papers focused on RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers) and Uterine Myomas and Treatments (3 papers). Tianshui Sun collaborates with scholars based in China. Tianshui Sun's co-authors include Zhuonan Liu, Qing Yang, Qing Yang, Fangfang Bi, Chuize Kong, Chiyuan Piao, Zhe Zhang, Zhe Zhang, Jianbin Bi and Yuanyuan An and has published in prestigious journals such as Molecular Cancer, Fertility and Sterility and Genomics.

In The Last Decade

Tianshui Sun

13 papers receiving 553 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of ubiquitination and deubiquitination in cancer metabolism

2020 318 citations Tianshui Sun, Zhuonan Liu et al. Molecular Cancer profile →

Peers

Tianshui Sun

MB

CR

ONCOL

PRM

IMMUN

Zhuonan Liu China

Fanling Meng China

Yuexin Hu China

Anup Sharma United States

Rui Gou China

Matteo Curtarello Italy

Simona Giglio Italy

Dilu Feng China

Maria Cardenas United States

Liangxian Cao United States

Zhuonan Liu China

Tianshui Sun

445 ×1.0

MB

159 ×0.9

CR

132 ×1.0

ONCOL

83 ×1.0

PRM

53 ×1.0

IMMUN

Citations per year, relative to Tianshui Sun Tianshui Sun (= 1×) peers Zhuonan Liu

Countries citing papers authored by Tianshui Sun

Since Specialization

Citations

This map shows the geographic impact of Tianshui Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianshui Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianshui Sun more than expected).

Fields of papers citing papers by Tianshui Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianshui Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianshui Sun. The network helps show where Tianshui Sun may publish in the future.

Co-authorship network of co-authors of Tianshui Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Tianshui Sun. A scholar is included among the top collaborators of Tianshui Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianshui Sun. Tianshui Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Liu, Zhuonan, et al.. (2025). METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination. Clinical and Translational Medicine. 15(2). e70232–e70232.

2.

Liu, Zhuonan, Tianshui Sun, Chiyuan Piao, Zhe Zhang, & Chuize Kong. (2022). METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma. Cell Communication and Signaling. 20(1). 36–36. 29 indexed citations

3.

Liu, Zhuonan, Tianshui Sun, Chiyuan Piao, Zhe Zhang, & Chuize Kong. (2021). METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression. Journal of Translational Medicine. 19(1). 209–209. 20 indexed citations

4.

Sun, Tianshui, Fangfang Bi, Zhuonan Liu, & Qing Yang. (2021). TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway. Journal of Translational Medicine. 19(1). 111–111. 36 indexed citations

5.

Bi, Fangfang, et al.. (2021). PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells. Frontiers in Oncology. 11. 643129–643129. 22 indexed citations

6.

Sun, Tianshui, Zhuonan Liu, Fangfang Bi, & Qing Yang. (2021). Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2. Molecular Oncology. 15(12). 3639–3658. 54 indexed citations

7.

Zhang, Ningning, et al.. (2020). Laparoscopic myomectomy using self-made retrieval bag to contain tissue extraction. Fertility and Sterility. 113(3). 679–680. 2 indexed citations

8.

Liu, Zhuonan, Tianshui Sun, Zhe Zhang, Jianbin Bi, & Chuize Kong. (2020). An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer. Genomics. 113(1). 896–907. 27 indexed citations

9.

Sun, Tianshui, Zhuonan Liu, & Qing Yang. (2020). The role of ubiquitination and deubiquitination in cancer metabolism. Molecular Cancer. 19(1). 146–146. 318 indexed citations breakdown →

10.

Zhang, Ningning, et al.. (2020). An effective method using laparoscopy in treatment of upper vaginal leiomyoma. Fertility and Sterility. 114(1). 185–186. 2 indexed citations

11.

Sun, Tianshui & Qing Yang. (2020). Chemoresistance‑associated alternative splicing signatures in serous ovarian cancer. Oncology Letters. 20(1). 420–430. 10 indexed citations

12.

Sun, Tianshui, Fangfang Bi, Zhuonan Liu, & Qing Yang. (2020). SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer. Aging. 12(13). 13281–13296. 24 indexed citations

13.

Zhang, Ningning, Tianshui Sun, & Qing Yang. (2019). An effective “water injection”-assisted method for excision of ovarian endometrioma by laparoscopy. Fertility and Sterility. 112(3). 608–609. 5 indexed citations

14.

Zhang, Ningning, et al.. (2019). An Effective Method Combining Various Endoscopes in the Treatment of Intravesical Migrated Intrauterine Device. Journal of Minimally Invasive Gynecology. 27(3). 582–582. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact